- Home
- CORT vs AXS Comparison
CORT vs AXS Comparison
Compare CORT & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- AXS
- Stock Information
- Founded
- CORT 1998
- AXS 2001
- Country
- CORT United States
- AXS Bermuda
- Employees
- CORT N/A
- AXS N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- AXS Property-Casualty Insurers
- Sector
- CORT Health Care
- AXS Finance
- Exchange
- CORT Nasdaq
- AXS Nasdaq
- Market Cap
- CORT 7.1B
- AXS 8.1B
- IPO Year
- CORT N/A
- AXS N/A
- Fundamental
- Price
- CORT $78.69
- AXS $100.66
- Analyst Decision
- CORT Strong Buy
- AXS Strong Buy
- Analyst Count
- CORT 4
- AXS 9
- Target Price
- CORT $142.00
- AXS $107.75
- AVG Volume (30 Days)
- CORT 1.1M
- AXS 547.9K
- Earning Date
- CORT 05-05-2025
- AXS 04-30-2025
- Dividend Yield
- CORT N/A
- AXS 1.75%
- EPS Growth
- CORT 8.36
- AXS 54.31
- EPS
- CORT 1.14
- AXS 10.08
- Revenue
- CORT $685,446,000.00
- AXS $6,055,200,000.00
- Revenue This Year
- CORT $35.85
- AXS $4.15
- Revenue Next Year
- CORT $35.22
- AXS $8.03
- P/E Ratio
- CORT $68.97
- AXS $10.00
- Revenue Growth
- CORT 30.93
- AXS 5.79
- 52 Week Low
- CORT $27.30
- AXS $68.02
- 52 Week High
- CORT $117.33
- AXS $103.85
- Technical
- Relative Strength Index (RSI)
- CORT 62.98
- AXS 55.47
- Support Level
- CORT $74.34
- AXS $98.97
- Resistance Level
- CORT $75.50
- AXS $103.85
- Average True Range (ATR)
- CORT 3.21
- AXS 1.81
- MACD
- CORT 0.50
- AXS -0.12
- Stochastic Oscillator
- CORT 92.19
- AXS 41.47
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.